| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/01/2001 | CA2376297A1 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 03/01/2001 | CA2376250A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 03/01/2001 | CA2316767A1 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 02/28/2001 | EP1078992A2 Polyclonal and Monoclonal Oligobodies (Synthetic, Oligonucleotide-Based Antibody-Like Reagents), and a method of producing oligobodies |
| 02/28/2001 | EP1078637A2 Composition for the treatment and prevention of nicotine addiction containing a nicotine receptor agonist and an anti-depressant or anti-anxiety drug |
| 02/28/2001 | EP1078636A1 Novel pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 02/28/2001 | EP1078634A1 Medicament for inhibiting NF-kB |
| 02/28/2001 | EP1078093A1 Vaccines, immunotherapeutics and methods for using the same |
| 02/28/2001 | EP1078075A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 02/28/2001 | EP1078062A2 Growth-associated protease inhibitor heavy chain precursor |
| 02/28/2001 | EP1078057A2 Cell signaling proteins |
| 02/28/2001 | EP1078054A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 02/28/2001 | EP1078044A2 Thrombolytic agents derived from streptokinase |
| 02/28/2001 | EP1078003A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) |
| 02/28/2001 | EP1077997A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
| 02/28/2001 | EP1077995A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077977A1 Retroviral protease inhibiting compounds |
| 02/28/2001 | EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 02/28/2001 | EP1077968A1 Naphtho[2,3-b]heteroar-4-yl derivatives |
| 02/28/2001 | EP1077967A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077964A1 Fumagillol derivatives and processes for preparing the same |
| 02/28/2001 | EP1077958A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077957A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 02/28/2001 | EP1077950A1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments |
| 02/28/2001 | EP1077948A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077945A1 Isoquinolines as urokinase inhibitors |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077942A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 02/28/2001 | EP1077936A1 Novel analogs of 16-hydroxyeicosatetraenoic acid |
| 02/28/2001 | EP1077935A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077930A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077925A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 02/28/2001 | EP1077912A1 Novel derivatives of 3,3-diphenylpropylamines |
| 02/28/2001 | EP1077728A1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 02/28/2001 | EP1077723A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions |
| 02/28/2001 | EP1077716A1 Method for the treatment of gastroesophageal reflux disease |
| 02/28/2001 | EP1077715A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 02/28/2001 | EP1077714A1 Use of arabinoxylans for preparing a composition |
| 02/28/2001 | EP1077707A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 02/28/2001 | EP1077706A1 Ionophore containing composition for modulating amyloidosis |
| 02/28/2001 | EP1077705A1 Potassium channel agonists |
| 02/28/2001 | EP1077700A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 02/28/2001 | EP1077695A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| 02/28/2001 | EP1077690A1 Use of amyloid inhibitors for modulating neuronal cell death |
| 02/28/2001 | EP1077689A1 Acylpeptide protease inhibitors to enhance cognitive function |
| 02/28/2001 | EP1077687A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 02/28/2001 | EP1077684A1 Effervescent preparations |
| 02/28/2001 | CN1285845A VEGI, an inhibitor of angiogenesis and tumor growth |
| 02/28/2001 | CN1285844A Compound |
| 02/28/2001 | CN1285843A Compound |
| 02/28/2001 | CN1285836A 3'-epimeric k-252a derivatives |
| 02/28/2001 | CN1285825A Novel allylthiopyridazine derivatives and process for preparing the same |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285821A Aryl Fused azapolycyclic compounds |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/28/2001 | CN1285817A Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 02/28/2001 | CN1285752A Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 02/28/2001 | CN1285744A Use of histamine for elevating blood histamine levels |
| 02/28/2001 | CN1285739A High drug load immediate and modified release oral dosage formulations and process for their production |
| 02/28/2001 | CN1285356A Depeptide compound, its medical salt or ester, the medicinal composition using same as active component and the application for treating and preventing cell from dying |
| 02/28/2001 | CN1062555C Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 02/28/2001 | CN1062457C Regulating agent for vegetative nerve of humanbody and preparation process thereof |
| 02/28/2001 | CA2317097A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/28/2001 | CA2317001A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/27/2001 | US6194598 Aminooxy-modified oligonucleotide synthetic intermediates |
| 02/27/2001 | US6194578 Growth hormone secretagogues; useful for prophylaxis and therapy of osteoporosis and/or frailty, insulin resistance in mammals, congestive heart failure, obesity, accelerating bone fracture repair reducing cachexia and protein loss |
| 02/27/2001 | US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety |
| 02/27/2001 | US6194469 Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids |
| 02/27/2001 | US6194458 1-(2-methoxyphenyl)-1-oxo-2-aza-(s)-4-i-butyl-4-phenylbutane, for example; treating various conditions including transplantation rejection of organs or tissues in a patient; immunosuppressant compositions |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | US6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors |
| 02/27/2001 | US6194439 Tricyclic polyhydroxylic tyrosine kinase inhibitors |
| 02/27/2001 | US6194430 Viral treatment |
| 02/27/2001 | US6194427 Brain disorders; psychological disorders; sleep disorders; anticonvulsants |
| 02/27/2001 | US6194426 5,6,7,8 tetrahydroindolizines derivatives |
| 02/27/2001 | US6194425 Viricides, antitumor agents |
| 02/27/2001 | US6194413 Hemoregulatory compounds |
| 02/27/2001 | US6194410 Antiserotonine agents; nervous system and psychological disorders |
| 02/27/2001 | US6194391 Cs-87 (title compound) induces a transient mutation in hiv-1 at the 70th codon of the reverse transcriptase region of the virus; administering to a human in need of therapy with a drug that induces a mutation in hiv-1 at another location |
| 02/27/2001 | US6194390 Administering hydroxyurea and a 2'-fluoropurine-dideoxy-nucleoside selected from the group of 2'-fluoro-2',3'-dide-oxyadenosine,-dideoxyinosine, and -dideoxyguanosine with a carrier or excipient; viricides; retroviruses; plant viruses |
| 02/27/2001 | US6194388 Immunomodulatory oligonucleotides |
| 02/27/2001 | US6194381 Therapeutic agent and method for feline AIDS virus infections and feline atopic dermatitis |
| 02/27/2001 | US6194380 Agents for promoting bone formation |
| 02/27/2001 | US6194212 Increasing gene expression by transducing eukaryotic cells with retrovirus vector having heterologous gene linked to regulatory sequence and scaffold attachment region of human interferon-beta gene, allowing cells to rest and express gene |
| 02/27/2001 | US6194206 Use of oligonucleotide telomerase inhibitors to reduce telomere length |
| 02/27/2001 | US6194186 Human protein kinase and kinase inhibitors |
| 02/27/2001 | US6194181 Producing epothiolones in a culture medium by providing microorganisms such as myxobacteria which produce epothiolones, and adding a complex-forming agent soluble in the culture medium, such as cyclodextrins; antitumor agents |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194140 HCV NS3 protein fragments having helicase activity and improved solubility |
| 02/27/2001 | US6194020 Conserving procyanidins(catechins); candy |
| 02/27/2001 | US6193970 Potentiating local inflammatory or immune response to administration of tumor antigen in mammalian subject by administering tumor antigen in form of tumor cells, or subcellular antigenic material and cytokine or cytokines |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193957 For prophylaxis and therapy of airway hyperresponsiveness or inflammatory reactions, e.g., asthma, allergic rhinitis, allergic dermatitis, allergic conjunctivitis, inflammatory bowel disease or rheumatoid arthritis |